| Product Code: ETC6739564 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Industry Life Cycle |
3.4 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Porter's Five Forces |
3.5 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic obstructive pulmonary disease (COPD) in China |
4.2.2 Growing geriatric population in China |
4.2.3 Rising awareness about COPD and its treatment options in China |
4.3 Market Restraints |
4.3.1 High cost associated with COPD treatment |
4.3.2 Limited access to advanced healthcare facilities in rural areas of China |
4.3.3 Stringent regulatory requirements for new COPD treatment products in China |
5 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Trends |
6 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, By Types |
6.1 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Combination Therapy, 2021- 2031F |
6.1.4 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Bronchodilators, 2021- 2031F |
6.1.5 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.1.6 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Phosphodiesterase Type 4 Inhibitor, 2021- 2031F |
6.1.7 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Mucokinetics, 2021- 2031F |
6.1.8 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Chronic Bronchitis, 2021- 2031F |
6.2.3 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Emphysema, 2021- 2031F |
6.3 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Import-Export Trade Statistics |
7.1 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Export to Major Countries |
7.2 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Imports from Major Countries |
8 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Key Performance Indicators |
8.1 Average number of COPD patients diagnosed annually in China |
8.2 Adoption rate of innovative COPD treatment therapies in China |
8.3 Average time taken for COPD patients to receive treatment after diagnosis in China |
9 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Opportunity Assessment |
9.1 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market - Competitive Landscape |
10.1 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Revenue Share, By Companies, 2024 |
10.2 China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here